GENB

Generate Biomedicines Inc

16.91

Sep 18 • 2:49 PM ET -0.21 (-1.22%)

Healthcare Biotechnology USA Mid NASD

Peers: RYTM KYMR BMRN CRNX APGE INCY KRYS VKTX AXSM NBIX

| Held by: ARKG VTI IWM VXF SBIO IWO JTEK SCHA VTWO IWN

Index	RUT
Market Cap	2.17B
Enterprise Value	1.78B
Income	-
Sales	-
Book/sh	3.56
Cash/sh	3.56
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	312
IPO	Feb 27, 2026

P/E	-
Forward P/E	-
PEG	-
P/S	-
P/B	4.76
P/C	4.75
P/FCF	-
EV/EBITDA	-
EV/Sales	-
Quick Ratio	8.30
Current Ratio	8.30
Debt/Eq	0.14
LT Debt/Eq	0.11
Option/Short	No / Yes

EPS (ttm)	-
EPS next Y	-2.29
EPS next Q	-0.56
EPS this Y	49.87%
EPS next Y	-0.73%
EPS next 5Y	26.80%
EPS past 3/5Y	- -
Sales past 3/5Y	- -
EPS Y/Y TTM	-
Sales Y/Y TTM	-
EPS Q/Q	-
Sales Q/Q	-
Earnings	Aug 06 BMO
EPS/Sales Surpr.	-2.30% 19.13%

Insider Own	56.98%
Insider Trans	0.00%
Inst Own	25.09%
Inst Trans	6.79%
ROA	-
ROE	-
ROIC	-
Gross Margin	-
Oper. Margin	-
Profit Margin	-
SMA20	3.76%
SMA50	11.56%
SMA200	20.30%
Trades

Shs Outstand	128.27M
Shs Float	55.21M
Short Float	13.50%
Short Ratio	6.95
Short Interest	7.46M
52W High	22.67 -25.40%
52W Low	11.00 53.74%
Volatility	6.27% 9.11%
ATR (14)	1.19
RSI (14)	56.68
Beta	-
Rel Volume	0.68
Avg Volume	1.07M
Volume	604,298

Perf Week	7.58%
Perf Month	-0.35%
Perf Quarter	16.71%
Perf Half Y	37.60%
Perf YTD	12.74%
Perf Year	-
Perf 3Y	-
Perf 5Y	-
Perf 10Y	-
Recom	1.00
Target Price	27.00
Prev Close	17.12
Price	16.91
Change %	-1.22%

Date	Action	Analyst	Rating Change	Price Target Change
Apr-13-26	Initiated	H.C. Wainwright	Buy	$16
Mar-24-26	Initiated	Piper Sandler	Overweight	$24
Mar-24-26	Initiated	Morgan Stanley	Overweight	$20
Mar-24-26	Initiated	Guggenheim	Buy	$30
Mar-24-26	Initiated	Goldman	Buy	$26
Mar-24-26	Initiated	Cantor Fitzgerald	Overweight

Sep-08-26 07:09AM	Generate Biomedicines Inc. to Participate in September Investor Conferences (GlobeNewswire)
Aug-28-26 07:59AM	Moderna raises $2.6B to support cancer work; FDA clears updated COVID vaccines (BioPharma Dive)
Aug-27-26 03:18PM	Cathie Wood Sends a $20 Million Signal on Broadcom Stock (GuruFocus.com)
Aug-25-26 11:10AM	Generate Biomedicines stock jumps as post-IPO lock-up set to expire (Proactive) +15.01%
Aug-17-26 12:12PM	Two Positions Make Up 80% of Nvidia's $63.4 Billion Portfolio (GuruFocus.com)
07:00AM	Loading…
Aug-06-26 07:00AM	Generate Biomedicines Inc. Reports Second Quarter 2026 Financial Results and Provides Business Update (GlobeNewswire)
06:21AM	Generate Biomedicines: Q2 Earnings Snapshot (Associated Press)
Jul-10-26 08:57AM	Cathie Wood Dumps AMD, Doubles Down on Meta Stock (GuruFocus.com) -8.87%
Jul-01-26 09:04AM	Cathie Wood Doubles Down on AI, Loads Up on Tesla, Palantir, and SpaceX (GuruFocus.com)
Jun-22-26 08:00AM	AdvanCell Signs 128,000 Square Foot, Full Building Lease at IQHQ's Innovation Park in Andover, Massachusetts (PR Newswire) +9.66%
May-28-26 04:20PM	Generate Biomedicines Inc. to Participate in Goldman Sachs 47th Annual Global Healthcare Conference (PR Newswire)
May-07-26 06:24AM	Generate Biomedicines: Q1 Earnings Snapshot (Associated Press) -11.21%
06:16AM	Generate Biomedicines, Inc. Reports First Quarter 2026 Financial Results and Provides Business Update (PR Newswire)

Generate Biomedicines, Inc. is a clinical-stage generative biology company pioneering the AI revolution in biotechnology and drug design and development. The company was founded in 2018, and is headquartered in Somerville, MA.

MBAMichael T. Nally

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
ARNOLD FRANCES	Director	Sep 02 '26	Proposed Sale	16.16	32,210	520,631		Sep 02 04:20 PM
ARNOLD FRANCES	Director	Sep 01 '26	Proposed Sale	16.00	1,000	16,002		Sep 01 04:27 PM
Nally Michael	Chief Executive Officer	Mar 04 '26	Buy	12.00	20,000	240,000	572,707	Mar 06 04:55 PM
Grous Beth	Chief People Officer	Mar 02 '26	Buy	16.00	300	4,800	300	Mar 02 06:05 PM
Silvers Jason	President & CFO	Mar 02 '26	Buy	16.00	2,000	32,000	1,000	Mar 02 05:54 PM
AFEYAN NOUBAR	Director	Mar 02 '26	Buy	16.00	4,687,500	75,000,000	15,264,724	Mar 02 05:52 PM
Mendillo Jane L	Director	Mar 02 '26	Buy	16.00	1,500	24,000	1,500	Mar 02 05:47 PM
AFEYAN NOUBAR	Director	Mar 02 '26	Buy	16.00	4,687,500	75,000,000	15,264,724	Mar 02 05:42 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

GENB

Generate Biomedicines Inc

Upgrade your Finviz experience